OncoSec Medical Inc (ONCSQ)

[twiz0019]

So, Dr. L., it sounds to me like you have a lot of experience in the bio field. Let me ask you this...Dr. Pierce and Oncosec contend that only 30% of patients respond to Keytruda because they don't have enough TIL's at the tumor site, and that ImmunoPulse WILL do the job of bringing those TIL's to the site and the Keytruda will then "take the brakes" off the TIL's and kill the cancer cells. I think what they are saying makes sense and their theory will prove out. What do YOU think??? And please don't answer with "maybe it will or maybe it won't". With your experience and background, you should be able to answer with a yes or no, and the reason for it. Thanks!